CURE Pharmaceutical Holding Corp. (OTC: CURR), a proprietary broad platform and wellness technology company, today announced results for the quarter ended June...
Are these penny stocks to buy now or avoid in September? The post Best Penny Stocks To Buy Now? 4 To Watch This Month appeared first...
The article Mydecine Sells Mindleap Health for $4 Million was originally published on Microdose. We’ve been reporting on the apparent troubles over...
Mydecine sells Mindleap and gets a much-needed cash infusion. The post Mydecine Sells Mindleap For C$4 Million appeared first on Green Market Report.
The launch of analyst coverage of psychedelics is a sign of how big the industry could become and why it is worth watching more closely now....
Clinical trial will be conducted as part of the ATMA Journey Centre's psychedelic-assisted therapist training program The post Filament administers psilocybin...
The article Cathie Wood’s ARK Invest Releases Psychedelic Research Report was originally published on Microdose. We’ve been reporting on controversial...
Filament Health Corp (OTCQB: FLHLF | NEO: FH) (FSE: 7QS), a clinical‐stage natural psychedelic drug development company, and ATMA Journey Centers, a...
Amidst the ongoing biotech market slowdown, companies are trying various ways to stay afloat. Some are going public, and some are taking on debt. The newest...
The Daily Hit is a recap of the top cannabis business stories for May 12, 2022. ON THE SITE Trulieve Cannabis Corp. on Track to do...
